Jejunoileal Atresia

Overview

• Definition: Jejunoileal atresia (JIA) is a congenital anomaly characterized by a complete obstruction of the jejunum or ileum, resulting from an intrauterine vascular accident that leads to ischemic damage and subsequent resorption of a segment of the bowel. It is distinct from duodenal atresia, which is typically a developmental arrest.
• Epidemiology: JIA occurs in approximately 1 in 5,000 to 1 in 10,000 live births, making it the most common cause of intestinal obstruction in neonates after Hirschsprung's disease and anal atresia. There is no significant sex predilection or clear genetic inheritance pattern, although rare familial cases exist. It is rarely associated with Down syndrome (unlike duodenal atresia).
• Classification: JIA is classified into five main types based on the morphology of the atresia, as described by Gross (and later updated by others):
• Type I (Membranous or Web atresia): Consists of a mucosal web or diaphragm with intact bowel wall and mesentery. Bowel length is typically normal.
• Type II (Blind ends separated by a fibrous cord): The atretic segments are separated by a fibrous cord, with the mesentery intact.
• Type IIIa (Blind ends separated by a V-shaped mesenteric defect): The atretic segments are completely separated, with a V-shaped defect in the mesentery, leading to a significant gap between the proximal and distal bowel.
• Type IIIb (Apple-peel or Christmas tree anomaly): A severe form where a large segment of the small bowel is missing. The distal ileum coils around a single mesenteric artery supplying it, resembling an apple peel or a Christmas tree. This is often associated with malrotation.
• Type IV (Multiple atresias): Consists of multiple atretic segments, which can be of any of the above types. Often presents as a "string of sausages" appearance.

Pathophysiology

• Mechanism: The predominant theory for JIA pathogenesis is an intrauterine mesenteric vascular accident (ischemia) occurring typically between the 8th and 12th weeks of gestation. This insult, such as an embolus, intussusception, strangulation by a hernia, or volvulus, obstructs blood flow to a segment of the developing bowel, leading to necrosis and subsequent resorption of the affected segment. This results in a gap or discontinuity in the intestinal lumen. The type of atresia (e.g., fibrous cord vs. mesenteric defect) depends on the extent of the vascular compromise.
• Risk Factors:
  • Intrauterine vascular compromise: Mechanisms include:
    • Mesenteric vessel thrombosis or embolism (e.g., from maternal vasculopathy, umbilical catheter complications, or thrombophilia).
    • Intussusception (transient).
    • Internal hernia or volvulus.
    • Entrapment of a bowel loop (e.g., in an omphalocele defect).
    • Maternal cocaine use (proposed, but not definitively proven).
  • Cystic Fibrosis: Meconium ileus, a manifestation of cystic fibrosis, can lead to increased intraluminal pressure and subsequent vascular compromise, resulting in "secondary" atresia.
  • Gastroschisis: Due to exposure of bowel to amniotic fluid and potential constriction at the abdominal wall defect, infants with gastroschisis have a higher incidence of JIA.
  • Omphalocele: Similarly, externalization of bowel can lead to vascular compromise.
  • Familial forms: Rare, autosomal recessive inheritance patterns have been described, particularly for multiple atresias (often associated with generalized intestinal dysmotility).
• Protective Factors: None specifically identified for primary prevention of JIA, as its etiology is largely stochastic and related to transient intrauterine events.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Bilious emesis: The most consistent and earliest symptom, typically within the first 24-48 hours of life, indicating obstruction distal to the ampulla of Vater.
  • Abdominal distension: Progressive distension, more pronounced with distal obstructions.
  • Failure to pass meconium: Often absent or delayed (beyond 24-48 hours).
  • Polyhydramnios: Detected antenatally in approximately 20-30% of cases, due to impaired fetal swallowing and absorption of amniotic fluid.
• Early Signs:
  • Bilious vomiting begins shortly after initiation of feeds.
  • Difficulty with feeding.
  • Mild abdominal distension.
• Advanced Signs:
  • Severe abdominal distension.
  • Signs of dehydration and electrolyte imbalance (if vomiting is prolonged).
  • Jaundice (due to dehydration or prolonged obstruction).
  • Signs of peritonitis (if perforation has occurred): abdominal tenderness, rigidity, erythema.
  • Sepsis (if perforation and infection are present).
• Atypical Presentations:
  • Non-bilious emesis (in very high jejunal obstructions before the entry of bile duct, although this is rare and more typical of gastric outlet or proximal duodenal obstructions).
  • Delayed presentation: May occur with incomplete obstructions or very distal, subtle atresias, or if the baby is not fed enterally early.

Physical Examination

• Inspection:
  • Abdominal distension: Often generalized, may be more prominent in the epigastrium with high jejunal obstruction or lower abdomen with ileal obstruction.
  • Visible peristalsis: May be evident over dilated bowel loops in thin newborns.
  • Dermal stigmata: Look for signs of gastroschisis or omphalocele repair if applicable.
  • Respiratory distress: Due to diaphragmatic elevation from severe abdominal distension.
• Palpation:
  • Abdomen typically soft and non-tender initially.
  • Loops of dilated bowel may be palpable.
  • Tenderness, guarding, or rigidity: Suggestive of peritonitis or perforation.
• Special Tests:
  • Digital rectal exam: To assess for meconium in the rectum (often absent or scant, "meconium plug" is non-specific). Usually not diagnostic for JIA.

Diagnostic Approach

History Taking

• Key Questions:
  • Onset and character of emesis: Bilious? Projectile? How soon after birth/feeding?
  • Meconium passage: When was the first meconium passed? What was its character?
  • Abdominal distension: When noted? Progressing?
  • Antenatal history: Polyhydramnios? Maternal drug use? USS findings?
  • Family history: Any similar conditions, particularly recurrent intestinal atresias or cystic fibrosis?
  • Associated anomalies: Were there any other congenital anomalies noted at birth?
• Red Flags:
  • Bilious emesis in a neonate: ALWAYS demands urgent investigation to rule out surgically correctable causes of intestinal obstruction, primarily volvulus neonatorum, which is a surgical emergency.
  • Progressive abdominal distension.
  • Absence of meconium passage for >24-48 hours.
  • Signs of sepsis or peritonitis.

Laboratory Tests

• First-Line:
  • Complete Blood Count (CBC): May show hemoconcentration if dehydrated, or leukocytosis if infection/perforation.
  • Electrolytes, Blood Urea Nitrogen (BUN), Creatinine: To assess hydration status and electrolyte imbalances (e.g., hypokalemia, hyponatremia from vomiting).
  • Blood gas: To assess acid-base balance.
  • C-reactive protein (CRP): Non-specific marker for inflammation/infection.
  • Blood culture: If sepsis is suspected.
• Confirmatory:
  • Sweat chloride test or CF gene panel: Should be considered if meconium ileus is suspected or if family history of cystic fibrosis exists, especially with complicated or multiple atresias.
• Monitoring:
  • Repeated electrolytes and CBC post-operatively and during fluid management.

Imaging

• Recommended:
  • Antenatal Ultrasound (US): May detect polyhydramnios, dilated bowel loops (single or multiple), or echogenic bowel (non-specific, but raises suspicion for CF). Not definitive for JIA but alerts to potential obstruction.
  • Abdominal X-ray (AXR):
    • Supine and erect views are crucial.
    • Classic findings:
      • Dilated loops of small bowel (more than 2-3 loops >1.5-2 cm in diameter).
      • Air-fluid levels.
      • Absence of gas in the distal bowel (distal to the obstruction).
      • "Triple bubble" sign (dilated stomach, duodenum, and proximal jejunum) for very high jejunal atresia, although more commonly associated with duodenal atresia.
      • No gas in the rectum and colon: A key sign suggesting complete obstruction.
      • Calcifications within the peritoneal cavity: Suggestive of meconium peritonitis (intrauterine bowel perforation).
      • Pneumoperitoneum: Indicates perforation.
  • Upper Gastrointestinal (GI) series with contrast: Generally not indicated as a primary diagnostic tool for JIA, but may be used to rule out malrotation with volvulus if plain films are equivocal or in cases of intermittent obstruction. In JIA, it would show dilated proximal bowel with an abrupt cut-off. Caution: Barium should be avoided if perforation is suspected; water-soluble contrast is safer.
  • Contrast enema (Lower GI series):
    • Indicated to differentiate between ileal atresia and meconium ileus, or other distal obstructions.
    • Findings in JIA: Typically shows a "microcolon" (small, unused colon) due to lack of meconium passage into the distal bowel. This finding is non-specific for the level of small bowel obstruction but confirms a distal obstruction.
    • Findings in meconium ileus: May show a microcolon and dilated, inspissated meconium pellets in the distal ileum, often with a "ground glass" appearance. Water-soluble contrast enema can sometimes be therapeutic for meconium ileus by dislodging inspissated meconium.
    • Not necessary if proximal jejunal atresia is clear on AXR.
• Advanced:
  • Computed Tomography (CT) scan: Rarely used in neonates for primary diagnosis of JIA due to radiation exposure and typical clarity of plain radiography. May be considered in complex cases (e.g., suspected perforation with abscess formation).

Management

Acute Management

• Immediate:
  • Nothing by Mouth (NPO): Crucial to prevent further distension and risk of aspiration.
  • Nasogastric (NG) tube insertion: Size 8-10F, placed to low intermittent suction for gastric decompression to reduce abdominal distension and prevent aspiration of bilious emesis.
  • Intravenous (IV) access: Obtain blood for labs and establish fluid resuscitation.
  • Fluid resuscitation: Isotonic crystalloids (e.g., normal saline) to correct dehydration and maintain adequate hydration. Adjust based on clinical status, electrolytes, and urine output.
  • Correction of electrolyte imbalances: Address hypokalemia, hyponatremia.
  • Parenteral nutrition initiation: Consider early initiation of total parenteral nutrition (TPN) especially if significant bowel resection is anticipated or prolonged NPO.
  • Broad-spectrum antibiotics: Prophylactic antibiotics are often started upon admission, particularly if perforation is suspected or prior to surgery (e.g., Ampicillin 100 mg/kg/day IV divided Q6H and Gentamicin 4 mg/kg/day IV divided Q24H, or a third-generation cephalosporin).
• Stabilization:
  • Continuous monitoring: Vital signs, urine output, abdominal girth.
  • Respiratory support: Assess for respiratory distress due to abdominal distension. May require intubation and mechanical ventilation in severe cases.
  • Thermoregulation: Neonates are prone to hypothermia; maintain normothermia.
• Emergency:
  • Surgical consultation: Immediate surgical consultation is paramount for all cases of suspected neonatal intestinal obstruction, especially with bilious emesis.
  • Prepare for surgery: Once diagnosed or highly suspected, prepare for surgical correction.

Chronic Management

• Pharmacological:
  • Post-operative pain management: Opioids (e.g., Fentanyl, Morphine) or paracetamol.
  • Antibiotics: Continue for 24-48 hours post-operatively, or longer if complicated (e.g., perforation, contamination).
  • Prokinetic agents (e.g., Erythromycin, Metoclopramide): Rarely used routinely but may be considered post-operatively in selected cases with severe dysmotility, under specialist guidance.
• Non-pharmacological:
  • Nutritional support:
    • TPN: Required initially in most cases until bowel function returns. Gradually wean as enteral feeds are advanced.
    • Enteral feeding: Start trophic feeds (e.g., 10-20 mL/kg/day human milk or specialized formula) cautiously once bowel function returns (bowel sounds, passage of flatus/stools, decreased NG output). Advance slowly to full enteral feeds.
  • Stoma care: If an ostomy is created (e.g., for diverting purposes or to facilitate later closure in very premature or unstable infants), meticulous stoma care is essential.
• Monitoring:
  • Growth and development: Regular follow-up with pediatric gastroenterology and nutrition services due to risk of short bowel syndrome (SBS) and malabsorption.
  • Electrolyte and nutritional status: Regular monitoring during TPN and after initiating enteral feeds.
  • Bowel function: Monitor for strictures, dysmotility, or adhesive obstructions.
  • Liver function tests: Routinely monitor LFTs for infants on prolonged TPN due to risk of TPN-associated cholestasis.

Treatment Algorithms

• First-Line:
  1. Pre-operative stabilization: NPO, NG decompression, IV fluids, correction of electrolytes, broad-spectrum antibiotics, IV access.
  2. Surgical repair:
     • Laparotomy (traditionally) or laparoscopy (increasingly for selected cases).
     • Resection of the atretic segment(s) and any ischemic/dilated proximal bowel.
     • Primary anastomosis: End-to-end or end-to-oblique anastomosis is preferred to preserve bowel length. The massively dilated proximal bowel often needs to be tapered or resected to achieve a good functional anastomosis and prevent functional obstruction.
     • Evaluation for multiple atresias: Always meticulously explore the entire small and large bowel to ensure no other atresias are missed.
     • Type I atresia (web): Excision of the web with or without limited resection and anastomosis.
     • Type IIIb (apple-peel): Often requires more extensive resection and careful anastomosis of the often small, distal bowel with the proximal dilated segment.
     • Gastrostomy placement: May be considered if difficulties with NG feeding are anticipated or for prolonged decompression needs.
• Second-Line: Not truly "second-line" as surgery is the primary treatment. However, variations in surgical approach:
  • Stoma (e.g., diverting ileostomy/jejunostomy): May be created instead of primary anastomosis in cases of severe abdominal contamination (perforation), gross disparity in bowel caliber, unstable patient, or extreme prematurity. The stoma is then closed in a second operation.
  • Serial transverse enteroplasty (STEP) or long small bowel tapering: For cases with extreme bowel caliber discrepancy or severe short bowel syndrome, to increase bowel length and improve motility.
• Refractory Cases:
  • Short Bowel Syndrome (SBS): If extensive bowel resection is necessary, leading to SBS. Management involves:
    • Intensive nutritional support: Long-term TPN, specialized formulas.
    • Bowel rehabilitation programs: Gradual advancement of enteral feeds, sometimes using trophins.
    • Pharmacological agents: Antidiarrheals (e.g., Loperamide), acid suppressants (H2 blockers, PPIs), somatostatin analogs (e.g., Octreotide) to reduce ostomy output, growth factors for intestinal adaptation.
    • Surgical bowel lengthening procedures: e.g., STEP, LILT (longitudinal intestinal lengthening and tailoring) for selected patients.
    • Intestinal transplantation: For patients with reversible short bowel syndrome, TPN-associated liver failure, or persistent, life-threatening complications.

Complications

• Common:
  • Delayed return of bowel function (post-operative ileus): Common after abdominal surgery.
  • Anastomotic leak: Rare but serious, requiring reoperation.
  • Adhesive small bowel obstruction: Can occur months to years post-operatively.
  • Stricture at the anastomotic site: May require re-operation or endoscopic dilatation.
  • Feeding difficulties and slow advancement of feeds.
• Serious:
  • Short Bowel Syndrome (SBS): The most dreaded long-term complication, especially with Type IIIb or multiple atresias. Leads to malabsorption, chronic diarrhea, growth failure, and TPN dependency.
  • Necrotizing enterocolitis (NEC): Increased risk in premature infants, especially after intestinal surgery.
  • Sepsis: From anastomotic leak, perforation, or often TPN-line associated.
  • TPN-associated liver disease/cholestasis: A significant complication of prolonged TPN.
• Long-term:
  • Failure to thrive / poor growth: Due to malabsorption, SBS, or feeding difficulties.
  • Neurodevelopmental delays: Can be associated with prematurity, critical illness, and malnutrition.
  • Enteral dysmotility: Functional obstruction.
  • Recurrent small bowel obstruction: Due to adhesions or strictures.
  • Psychosocial challenges: For patient and family, especially with chronic illness.

Prognosis

• Factors:
  • Length of remaining small bowel: The most critical determinant of prognosis, particularly for short bowel syndrome.
  • Presence of ileocecal valve: Crucial for slowing transit time and preventing bacterial overgrowth.
  • Type of atresia: Type IIIb and Type IV (multiple atresias) have poorer prognoses due to associated shorter bowel length and often comorbidities.
  • Associated anomalies: Presence of other congenital anomalies (e.g., gastroschisis with associated atresia) can worsen prognosis.
  • Complications: Post-operative complications like sepsis, anastomotic leak, or development of SBS significantly impact outcome.
  • Development of TPN-associated liver disease: A major cause of mortality in SBS.
• Survival:
  • Overall survival rate for isolated JIA is excellent, often >90-95% in developed countries.
  • Survival decreases significantly with complex atresias (e.g., Type IIIb, IV) and associated conditions like gastroschisis or very short bowel syndrome.
  • Mortality is primarily due to complications like sepsis, organ failure (e.g., TPN-associated liver disease), and severe prematurity.
• Quality of Life:
  • Most children with isolated JIA, after successful surgical repair and establishment of full enteral feeding, go on to lead normal lives with normal growth and development.
  • Children with SBS requiring long-term TPN or extensive bowel rehabilitation face significant challenges, including frequent hospitalizations, reliance on medical devices, and potential for developmental delays and psychosocial issues.

Prevention

• Primary:
  • No specific primary prevention strategies for JIA, as its etiology is often attributed to stochastic intrauterine vascular accidents.
  • Maternal health: Optimizing maternal health during pregnancy may indirectly reduce some risks (e.g., avoiding maternal cocaine use, though evidence for direct causation is weak).
• Secondary:
  • Antenatal diagnosis: Early detection of polyhydramnios or dilated bowel loops on antenatal ultrasound allows for appropriate planning for delivery at a tertiary care center with pediatric surgical capabilities. This enables prompt diagnosis and management after birth, potentially improving outcomes.
  • Prompt evaluation of bilious emesis: Rapid assessment and surgical consultation for any neonate with bilious emesis is crucial for early diagnosis and intervention, minimizing complications.
• Tertiary:
  • Early and aggressive nutritional management: Prevents malnutrition and promotes bowel adaptation post-operatively.
  • Careful surgical technique: Minimizing bowel resection, careful anastomosis, and prevention of future adhesions.
  • Management of SBS: Multidisciplinary approach for children with SBS to optimize growth, minimize TPN dependence, and prevent TPN-associated complications.

Special Populations

• Pediatric: JIA is exclusively a pediatric condition, specifically neonatal. The management considerations outlined above are tailored for this age group.
• Geriatric: Not applicable.
• Pregnancy: Not applicable to the patient, but antenatal diagnosis in the fetus influences obstetric management (delivery planning) for the pregnant mother.
• Comorbidities:
  • Gastroschisis: JIA incidence is significantly higher (10-15%) in infants with gastroschisis. Management is complicated by bowel inflammation, potential for malrotation, and further short bowel length. Surgical repair of the atresia is often performed at the time of gastroschisis closure or staged repair.
  • Cystic Fibrosis: A subset of JIA can be secondary to complicated meconium ileus in CF. Screening for CF is essential if meconium ileus is suspected or family history is present. Prognosis impacted by CF lung and pancreatic disease.
  • Malrotation: Type IIIb JIA ("apple-peel") is often associated with malrotation. This requires careful reduction of any volvulus and Ladd's procedure if surgically indicated, in addition to atresia repair.
  • Other congenital anomalies: While JIA is often an isolated anomaly, other congenital heart defects or genitourinary anomalies may coexist (less commonly than with duodenal atresia), necessitating comprehensive evaluation.

Clinical Pearls

• Diagnostic:
  • Bilious emesis in a neonate is always a surgical emergency until proven otherwise. Think volvulus first, then other obstructions like atresia or Hirschsprung’s.
  • A plain abdominal X-ray can be highly diagnostic; look for dilated loops and absence of distal gas.
  • A microcolon on contrast enema strongly suggests a distal small bowel obstruction, particularly atresia or complicated meconium ileus.
• Treatment:
  • "Fix the baby, then the bowel." Resuscitation and stabilization are paramount before surgery.
  • Preserve as much bowel length as possible, but ensure viable, well-perfused bowel for anastomosis. Reaching healthy, non-dilated bowel for the proximal segment is crucial to prevent functional obstruction.
  • Aggressive post-operative nutritional support is vital, often starting with TPN.
• Pitfalls:
  • Misinterpreting plain films: Overlooking subtle signs of obstruction or mistaking bowel gas patterns for normal.
  • Delay in surgical consultation: Delay in diagnosing and treating JIA can lead to bowel necrosis, perforation, sepsis, and increased morbidity/mortality.
  • Inadequate bowel exploration: Missing multiple atresias, especially in Type IV, which requires meticulous examination of the entire small bowel.
  • Ignoring severe caliber discrepancy: Anastomosing a massively dilated proximal segment to a very small distal segment without tapering can lead to functional obstruction.

Recent Updates

• Guidelines:
  • No single, universal guideline specifically for JIA. Management principles are generally incorporated into broader neonatal surgery guidelines. Key areas of focus in recent years include:
    • Minimally invasive approaches: Increasing use of laparoscopy for diagnosis and repair in selected, stable cases, aiming for reduced pain and faster recovery.
    • Emphasis on bowel preservation: Surgical techniques like tapering enteroplasty and serial transverse enteroplasty (STEP) for managing significant bowel length discrepancy and short bowel syndrome.
    • Standardized protocols for TPN and bowel rehabilitation: To optimize nutritional outcomes and minimize complications for infants with short bowel syndrome.
• Evidence:
  • Studies continue to refine surgical techniques, particularly for managing extremely dilated proximal bowel and optimizing outcomes for short bowel syndrome.
  • Research into intestinal adaptation and growth factors to improve outcomes for SBS patients.
  • Long-term follow-up studies confirm excellent outcomes for isolated JIA but highlight ongoing challenges for complex cases.
• Controversies:
  • Role of laparoscopy vs. laparotomy: While laparoscopy offers advantages, its role in unstable or complex JIA cases is still debated.
  • Timing and necessity of stoma vs. primary anastomosis: Decision-making often depends on surgeon preference, patient stability, and intraoperative findings (e.g., contamination, severe caliber discrepancy).
  • Optimal management of dilated proximal segment: Whether to resect, plicate, or taper remains a subject of surgical judgment and ongoing discussion.

Key References

• Guidelines:
  • American Academy of Pediatrics (AAP) Surgery Section clinical guidelines (general principles apply).
  • European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines on parenteral and enteral nutrition in neonates (relevant for post-operative care and short bowel syndrome).
• Studies:
  • Gross, R. E. (1953). The Surgery of Infancy and Childhood: Its Principles and Techniques. WB Saunders Co. (Classic classification of atresias).
  • Dalla Vecchia, L. K., et al. (1998). Jejunoileal atresia: An 18-year experience with 107 cases. Archives of Surgery, 133(5), 490-496. (Large series outlining types and outcomes).
  • Bianchi, A. (2003). Intestinal lengthening for short bowel syndrome. Seminars in Pediatric Surgery, 12(3), 195-201. (Discusses surgical techniques for short bowel syndrome).
• Reviews:
  • Rescorla, F. J. (2018). Jejunoileal Atresia and Stenosis. In Coran, A. G., et al. (Eds.), Pediatric Surgery (7th ed.). Elsevier.
  • Teitelbaum, D. H., & Goulet, O. (2020). Short Bowel Syndrome. In Kliegman, R. M., et al. (Eds.), Nelson Textbook of Pediatrics (21st ed.). Elsevier.

---

Disclaimer: This information is for educational purposes only and should not be considered medical advice. Clinical decisions must always be made by a qualified healthcare professional, taking into account the individual patient's medical history, current condition, and local clinical guidelines. This content is not a substitute for professional medical judgment. Always consult with a physician or other healthcare provider for diagnosis and treatment of any medical condition.